Cite
HARVARD Citation
Macaluso, F. et al. (2019). A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease. Journal of Crohn's and colitis. pp. 209-217. [Online].